{"id":283454,"date":"2026-10-01T11:36:42","date_gmt":"2026-10-01T06:06:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=283454"},"modified":"2026-10-01T11:36:42","modified_gmt":"2026-10-01T06:06:42","slug":"molbio-diagnostics-share-price-hdfc-mf","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/molbio-diagnostics-share-price-hdfc-mf\/","title":{"rendered":"Molbio Diagnostics Share Price Target Rs 1,600: Stock Jumps 5% as HDFC Mutual Fund Buys 1.99% in Bulk Deal"},"content":{"rendered":"

Molbio up over 5% on 1 Oct, about 71% above IPO price. HDFC MF buys 23 lakh shares at Rs 1,315. Jefferies Buy, target Rs 1,600. High Rs 1,686.80.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Molbio Diagnostics share price rose over 5% on 1 October after HDFC Mutual Fund bought about 1.99% of the company, roughly 23 lakh shares at Rs 1,315 each, in a bulk deal. The seller was Business Excellence Trust III, an investment vehicle of Motilal Oswal Alternates, which has been trimming its holding. The buying follows Jefferies initiating coverage with a Buy rating and a Rs 1,600 target, about 27% above the 29 September close of Rs 1,255.60. The stock still trades below its post-listing high of Rs 1,686.80.<\/p>\n<\/p><\/div>\n

Molbio Diagnostics is a Goa-based point-of-care diagnostics company whose Truenat platform tests for more than 30 diseases. The Molbio Diagnostics stock has had a volatile run since listing at Rs 980 on 17 August against an IPO price of Rs 807. It climbed to a 52-week high of Rs 1,686.80, fell about 26% to Rs 1,255.60 by 29 September, and then drew fresh buyers through a bulk deal and a Jefferies Buy rating.<\/p>\n

If you are searching for the Molbio Diagnostics share price target or the reason behind today’s move, this article covers the Molbio Diagnostics bulk deal in which HDFC Mutual Fund bought from Business Excellence Trust III, a Motilal Oswal Alternates vehicle, what Jefferies expects through operating leverage, how Molbio earns revenue, and the key risks. Price data is based on NSE and BSE figures, so recheck it before acting.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n